BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Pancreatic

Below is an extended Pancreatic research listing. Click here to return to the Pancreatic main in depth entry.

Recent Publications on Pancreatic:

A case of long survival in poorly differentiated small cell carcinoma of the pancreas. 30th August, 2008
Department of Surgery, College of Medicine, Hanyang University, Hanyang
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.
BACKGROUND.: To the authors' knowledge, there is no established...
Direct Link
30th August, 2008
Center for Cancer and Blood Disorders, Fort Worth, Texas.
Unusual serum electrophoresis pattern in a woman with pancreatic carcinoma.
BACKGROUND.: To the authors'' knowledge, there is no established...
Direct Link
30th August, 2008
Department of Clinical Chemistry, University Hospital Ghent, Ghent,
Chromatin-bound mitogen-activated protein kinases transmit dynamic signals in transcription complexes in {beta}-cells.
MAPK pathways regulate transcription through phosphorylation of...
Direct Link
30th August, 2008
Department of Pharmacology, University of Texas Southwestern Medical
The natural history of hereditary pancreatitis: A national series.
BACKGROUND AND AIMS: Prevalence and natural history of hereditary...
Direct Link
30th August, 2008
France.
Nitric Oxide Regulates Tumor Cell Cross-Talk with Stromal Cells in the Tumor Microenvironment of the Liver.
Tumor progression is regulated through paracrine interactions between...
Direct Link
30th August, 2008
From the Department of Physiology,* Gastroenterology Research Unit, Cancer
PAR2 Exerts Local Protection against Acute Pancreatitis via Modulation of MAP Kinase and MAP Kinase Phosphatase Signaling.
During acute pancreatitis, protease-activated receptor 2 (PAR2) can be...
Direct Link
30th August, 2008
Department of Pharmacology, Yonsei University College of Medicine, Seoul,
Expression of neurexin, neuroligin and their cytoplasmic binding partners in the pancreatic {beta}-cells and the involvement of neuroligin in insulin secretion.
The composition of the beta-cell exocytic machinery is very similar to...
Direct Link
30th August, 2008
Department of Medicine, University of California, San Diego, 9500 Gilman
[Genetic risk factors in chronic pancreatitis.]
Chronic pancreatitis is a persistent inflammatory disorder of the...
Direct Link
30th August, 2008
Boston University Department of Molecular and Cell Biology Boston USA.
Clinico-pathological discrepancies in the diagnoses of solid malignancies.
Autopsy is a valuable tool in evaluating diagnostic accuracy. Solid...
Direct Link
30th August, 2008
Department of Pathology, Sao Paulo University Medical School, Sao Paulo,
Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients.
We recently cloned a variant form of erythropoietin-producing hepatocyte...
Direct Link
30th August, 2008
Cancer Vaccine Development Division, Kurume University Research Center for
Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth.
Pancreatic ductal adenocarcinoma (PDAC) shows the worst mortality among...
Direct Link
30th August, 2008
Laboratory of Molecular Medicine, Human Genome Center, Institute of
Divalent cations modulate the integrin-mediated malignant phenotype in pancreatic cancer cells.
We have previously demonstrated that pathophysiological shifts in the...
Direct Link
30th August, 2008
Department of Surgery, University of California, Veterans Affairs San
Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue. 30th August, 2008
Department of Oncology-Pathology, Karolinska Institutet, Stockholm,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional